376 related articles for article (PubMed ID: 26781226)
1. Expanding the clinicopathological spectrum of late cutaneous Lyme borreliosis (acrodermatitis chronica atrophicans [ACA]): A prospective study of 20 culture- and/or polymerase chain reaction (PCR)-documented cases.
Lenormand C; Jaulhac B; Debarbieux S; Dupin N; Granel-Brocard F; Adamski H; Barthel C; Cribier B; Lipsker D
J Am Acad Dermatol; 2016 Apr; 74(4):685-92. PubMed ID: 26781226
[TBL] [Abstract][Full Text] [Related]
2. A two year prospective study to compare culture and polymerase chain reaction amplification for the detection and diagnosis of Lyme borreliosis.
Picken MM; Picken RN; Han D; Cheng Y; Ruzic-Sabljic E; Cimperman J; Maraspin V; Lotric-Furlan S; Strle F
Mol Pathol; 1997 Aug; 50(4):186-93. PubMed ID: 9350301
[TBL] [Abstract][Full Text] [Related]
3. Skin Changes in Suspected Lyme Disease.
Vržogić P; Perica A
Acta Dermatovenerol Croat; 2023 Dec; 31(4):225-228. PubMed ID: 38651851
[TBL] [Abstract][Full Text] [Related]
4. Polymerase chain reaction for detection of Borrelia burgdorferi DNA in skin lesions of early and late Lyme borreliosis.
von Stedingk LV; Olsson I; Hanson HS; Asbrink E; Hovmark A
Eur J Clin Microbiol Infect Dis; 1995 Jan; 14(1):1-5. PubMed ID: 7729446
[TBL] [Abstract][Full Text] [Related]
5. Interstitial granulomatous dermatitis with histiocytic pseudorosettes: a new histopathologic pattern in cutaneous borreliosis. Detection of Borrelia burgdorferi DNA sequences by a highly sensitive PCR-ELISA.
Moreno C; Kutzner H; Palmedo G; Goerttler E; Carrasco L; Requena L
J Am Acad Dermatol; 2003 Mar; 48(3):376-84. PubMed ID: 12637917
[TBL] [Abstract][Full Text] [Related]
6. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
Lebech AM
APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
[TBL] [Abstract][Full Text] [Related]
7. Detection of Borrelia burgdorferi sensu lato in lesional skin of patients with erythema migrans and acrodermatitis chronica atrophicans by ospA-specific PCR.
Moter SE; Hofmann H; Wallich R; Simon MM; Kramer MD
J Clin Microbiol; 1994 Dec; 32(12):2980-8. PubMed ID: 7883886
[TBL] [Abstract][Full Text] [Related]
8. Molecular subtyping of Borrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans.
Wienecke R; Zöchling N; Neubert U; Schlüpen EM; Meurer M; Volkenandt M
J Invest Dermatol; 1994 Jul; 103(1):19-22. PubMed ID: 8027576
[TBL] [Abstract][Full Text] [Related]
9. Skin manifestations of lyme borreliosis: diagnosis and management.
Müllegger RR; Glatz M
Am J Clin Dermatol; 2008; 9(6):355-68. PubMed ID: 18973402
[TBL] [Abstract][Full Text] [Related]
10. [Skin manifestations in Lyme borreliosis. 6: Acrodermatitis chronica atrophicans (ACA)].
Hassler D
Fortschr Med; 1998 Feb; 116(5):34-6. PubMed ID: 9553302
[No Abstract] [Full Text] [Related]
11. Histopathology and immunophenotype of acrodermatitis chronica atrophicans correlated with ospA and ospC genotypes of Borrelia species.
Brandt FC; Ertas B; Falk TM; Metze D; Böer-Auer A
J Cutan Pathol; 2015 Oct; 42(10):674-92. PubMed ID: 26156537
[TBL] [Abstract][Full Text] [Related]
12. Acrodermatitis chronica atrophicans in an 11-year-old girl.
Muellegger RR; Schluepen EM; Millner MM; Soyer HP; Volkenandt M; Kerl H
Br J Dermatol; 1996 Oct; 135(4):609-12. PubMed ID: 8915157
[TBL] [Abstract][Full Text] [Related]
13. Course of Borrelia burgdorferi DNA shedding in urine after treatment.
Aberer E; Bergmann AR; Derler AM; Schmidt B
Acta Derm Venereol; 2007; 87(1):39-42. PubMed ID: 17225014
[TBL] [Abstract][Full Text] [Related]
14. [Dermatological aspects of Lyme borreliosis].
Lipsker D
Med Mal Infect; 2007; 37(7-8):540-7. PubMed ID: 17391884
[TBL] [Abstract][Full Text] [Related]
15. The expanding spectrum of cutaneous borreliosis.
Eisendle K; Zelger B
G Ital Dermatol Venereol; 2009 Apr; 144(2):157-71. PubMed ID: 19357623
[TBL] [Abstract][Full Text] [Related]
16. [The dermatologic spectrum of Lyme borreliosis].
Aberer E
Wien Med Wochenschr; 1995; 145(7-8):165-70. PubMed ID: 7610665
[TBL] [Abstract][Full Text] [Related]
17. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
[TBL] [Abstract][Full Text] [Related]
18. Long-term prognosis in patients treated for erythema chronicum migrans and acrodermatitis chronica atrophicans.
Hulshof MM; Vandenbroucke JP; Nohlmans LM; Spanjaard L; Bavinck JN; Dijkmans BA
Arch Dermatol; 1997 Jan; 133(1):33-7. PubMed ID: 9006370
[TBL] [Abstract][Full Text] [Related]
19. Identification of three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B. garinii, and B. afzelii) among isolates from acrodermatitis chronica atrophicans lesions.
Picken RN; Strle F; Picken MM; Ruzic-Sabljic E; Maraspin V; Lotric-Furlan S; Cimperman J
J Invest Dermatol; 1998 Mar; 110(3):211-4. PubMed ID: 9506437
[TBL] [Abstract][Full Text] [Related]
20. Clinical spectrum of skin manifestations of Lyme borreliosis in 204 children in Austria.
Glatz M; Resinger A; Semmelweis K; Ambros-Rudolph CM; Müllegger RR
Acta Derm Venereol; 2015 May; 95(5):565-71. PubMed ID: 25366035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
